Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study.
Ibrahim CilAhmet KüçükardaMuhammed Mustafa AtcıSaban SecmelerNail PaksoyFerhat FerhatogluNaziye AkMurat AyhanDeniz Tataroglu OzyukselerArif Hakan OnderOkan AvcıAbdilkerim OymanIlker Nihat OktenIlkay GulturkBaran AkagunduzTugba BasogluEmre CakirIlhan HacibekirogluMelike OzcelikAdnan AydinerPublished in: Tumori (2021)
The efficacy of T-DM1 was acceptable and it was generally well-tolerated among older patients with advanced HER2-positive breast cancer.